Valbiotis Company
Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. The company develops Valedia, a product that is in Phase II clinical trials for the treatment of type 2 diabetes.
Industry:
Wellness & Fitness
Headquarters:
La Rochelle, Poitou-Charentes, France
Zip:
11-50
Founded Date:
2014-01-01
Employees Number:
11-50
Acquisitions Number:
1
Investors Number:
29722073
Total Funding:
$10M to $50M
Estimated Revenue:
2017-06-08
Last Funding Date:
Post-IPO Equity
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership